4//SEC Filing
Raines Heather 4
Accession 0001493152-24-008274
CIK 0000315545other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 9:22 AM ET
Size
7.2 KB
Accession
0001493152-24-008274
Insider Transaction Report
Form 4
Raines Heather
Chief Financial Officer
Transactions
- Disposition to Issuer
8% Unsecured Convertible Promissory Note due 2022
2024-02-28$50000.00/shExercise: $2.86From: 2021-08-16Exp: 2023-08-16→ Series D-1 Convertible Preferred Stok (17,471 underlying)
Footnotes (3)
- [F1]On February 28, 2024, the Issuer repaid $50,000 of the amount outstanding under the 8% unsecured convertible promissory note due 2022 (the "Note").
- [F2]The Reporting Person may elect to convert the outstanding principal and interest of the Note as follows: (i) the Note is convertible into shares of Series D-1 Convertible Preferred Stock, par value $0.001 per share ("Series D-1 Preferred Stock") at a price per share equal to $2.862; (ii) in the event the Issuer conducts a qualified equity financing in the aggregate amount of $20 million, the Note is convertible into the shares of capital stock being issued by the Issuer in such qualified equity financing at the price per share being paid by the investors in such qualified equity financing; and (iii) in the event the Issuer conducts a qualified debt financing with more favorable terms than the Note in the aggregate amount of $20 million, the Note may be exchanged for the debt instrument being issued by the Issuer in such qualified debt financing.
- [F3]Each share of Series D-1 Preferred Stock is convertible into 10 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The Series D-1 Preferred Stock will automatically convert into Common Stock on June 20, 2026, unless earlier converted into Common Stock in accordance with the terms of the Certificate of Designation for the Series D-1 Preferred Stock.
Documents
Issuer
PROVECTUS BIOPHARMACEUTICALS, INC.
CIK 0000315545
Entity typeother
Related Parties
1- filerCIK 0001770650
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 9:22 AM ET
- Size
- 7.2 KB